4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-015543
Chief Financial Officer acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Goeltz II Robert C. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-04-10 | Exercise or conversion : show line 1 in the form | +3,000 | $4.47 | $13,418 | 12,789 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-04-10 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −3,000 | 214,658 | D |
Loading xslF345X03/doc1.xml…